Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Iovance Biotherapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 273
- +37 vs. Q4 2023
- Shares held
- 217.2M
- +9.90M (+4.8%) vs. Q4 2023
- Total value
- $3.22B
- +$1.53B (+90.9%) vs. Q4 2023
- New holders
- 70
- 90 more added
- Sold out
- 33
- 83 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Martingale Asset Management L P | 0 | $0 | 0.00% | −10,741−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −10,478−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −4,323−100.0% | Sold out |
| BKM Wealth Management, LLC | 0 | $0 | 0.00% | −570−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −117−100.0% | Sold out |
| Scarborough Advisors, LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |